Syngene International’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Syngene is a contract research organization that specializes in providing drug discovery and development of medicinal chemistry. Read more

582 Followers on Owler
582 Followers on Owler
582 Followers on Owler
582 Followers on Owler

Syngene is a contract research organization that specializes in providing drug discovery and development of medicinal chemistry. Read more

Jonathan Hunt's photo - CEO of Syngene International

CEO

Jonathan Hunt

CEO Approval Rating

75/100

Founded:

1993

Status:

PublicSubsidiary of Biocon LimitedBombay Stock Exchange539268

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Jubilant Life Sciences is one of Syngene International's top rivals. Jubilant Life Sciences was founded in Noida, Uttar Pradesh} in 1978. Like Syngene International, Jubilant Life Sciences also competes in the Life Sciences space. Compared to Syngene International, Jubilant Life Sciences generates $958.8M more revenue.

Charles River is Syngene International's #2 competitor. Charles River was founded in 1947, and is headquartered in Wilmington, Massachusetts. Charles River is in the Health Care Services industry. Charles River generates $2.6B more revenue vs. Syngene International.

GVK BIO is a top competitor of Syngene International. GVK BIO's headquarters is in Hyderabad, Andhra Pradesh, and was founded in 2001. Like Syngene International, GVK BIO also operates in the Life Sciences space. GVK BIO generates 58% of Syngene International's revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is PPD a competitor of Syngene International?

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$255.4M

Syngene International's revenue is the ranked 12th among it's top 10 competitors. The top 10 competitors average 3.5B. Over the last three quarters, Syngene International's revenue has decreased by 23%. Specifically, in Q2 2020's revenue was $55.9M; in Q1 2020, it was $84.7M; in Q4 2019, it was $72.7M.

Acquisitions

No recent acquisitions found related to Syngene International

Investments

No recent investments found related to Syngene International

Syngene International News

October 30, 2020The Hindu Business Line

Syngene eases clients' path to drug discovery

Syngene International - an integrated research, development and manufacturing services company - has ... See more »
October 22, 2020The Hindu Business Line

Syngene posts 2% rise in Q2 profits at 84 crore

Our Bureau A robust operating performance during the second quarter of the current fiscal has helped ... See more »
October 22, 2020India Infoline

Syngene International drops 3% post Q2 earnings; Records PAT of Rs84cr

Syngene highlighted that PAT rose by 2% during Q2FY21 if compared to Q2FY20 PAT excluding exceptional... See more »
October 22, 2020India Infoline

Syngene Q2 net profits lower 34% at Rs84cr on a yoy basis

Syngene reported growth in top line but the bottom line faltered during the quarter.... See more »
October 22, 2020Pharmabiz

Syngene reports second quarter revenue at Rs. 533 crore up by 10% year on year

Syngene International posted total revenue of Rs. 533 crore in Q2 compared to Rs. 485 crore in the co... See more »
October 22, 2020Equity Bulls

Syngene International - Q2FY21 conference call takeaways - YES Securities

Syngene International - Q2FY21 conference call takeaways - YES Securities...... See more »
October 21, 2020Equity Bulls

Syngene International Ltd Q2FY21 consolidated net profit at Rs. 84.1 crore

Syngene International Ltd Q2FY21 consolidated net profit at Rs. 84.1 crore...... See more »

Syngene International Press Releases

September 18, 2014BUSINESS WIRE INDIA

Silver Leaf Oak Acquires 10% Stake in Syngene International, Biocon’s Research Services Subsidiary

Silver Leaf Oak (Mauritius) Limited (“Silver Leaf”), an investment vehicle advised by India Value Fun... See more »
June 4, 2014WEB NEWSWIRE

Bristol-Myers Squibb and Syngene International Extend Research Collaboration

Bristol-Myers Squibb (NYSE: BMY) and Syngene International, India's largest contract research organiz... See more »

Syngene International Videos

Social Media

Headquarters

Biocon Park, Bommasandra Industrial Estate Phase-IV, Jigani Link Road

Inn Bangalore, Karnataka560 099

91-80-2808-2808

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Syngene is a contract research organization that specializes in providing drug discovery and development of medicinal chemistry. Syngene International was founded in 1993. Syngene International's headquarters is located in Inn Bangalore, Karnataka, IN...

CEO

Syngene International's CEO, Jonathan Hunt, currently has an approval rating of 75%. Syngene International's primary competitors are Jubilant Life Sciences, Charles River & GVK BIO.

Website

syngeneintl.com

Frequently Asked Questions about Syngene International

  1. When was Syngene International founded?

    Syngene International was founded in 1993
  2. Who is Syngene International's CEO?

    Syngene International's CEO is Jonathan Hunt
  3. How much revenue does Syngene International generate?

    Syngene International generates $255.4M in revenue
  4. How much funding does Syngene International have?

    Syngene International has historically raised $0 in funding
  1. Where is Syngene International's headquarters?

    Syngene International's headquarters is in Inn Bangalore Karnataka, IN
  2. How many employees does Syngene International have?

    Syngene International has 6,148 employees
  3. What sector does Syngene International operate in?

    Syngene International is in Life Sciences, Medical Research & Laboratories
  4. Who are Syngene International's competitors?

    Syngene International's top competitors are Jubilant Life Sciences, Charles River, GVK BIO